R-CDOP regimen
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Overview
Overview
R-CDOP regimen refers to a regimen consisting of rituximab, cyclophosphamide, liposomal doxorubicin (Caelyx), vincristine, prednisone used to treat non-Hodgkin lymphoma.[1]
Regimen
Regimen
RRituximab
CCyclophosphamide
DDoxorubicin (Caelyx)
OVincristine (Oncovin)
PPrednisone
References
References
- ↑ 1.0 1.1 Martino R, Perea G, Caballero MD, Mateos MV, Ribera JM, de Oteyza JP; et al. (2002). “Cyclophosphamide, pegylated liposomal doxorubicin (Caelyx), vincristine and prednisone (CCOP) in elderly patients with diffuse large B-cell lymphoma: results from a prospective phase II study”. Haematologica. 87 (8): 822–7. PMID 12161358.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH